Thermo Fisher Scientific (TMO)
| Sector: | Health Care |
| Super Investor Stats: | |
| Ownership count: | 7 |
| Ownership rank: | 44 |
| % of all portfolios: | 0.22% |
| Hold Price * : | $618.57 |
| Total insider Buys/Sells last 6 months: |
| Transactions | Total |
| Buys |
0 |
$0 |
| Sells |
125 |
$86,470,242 |
|
Portfolio Manager |
% of portfolio |
Recent activity |
Shares |
Value |
| ≡ |
Wallace Weitz - Weitz Large Cap Equity Fund |
4.91 |
|
75,000 |
46,393,000 |
| ≡ |
Polen Capital Management |
4.48 |
Reduce 9.52% |
2,806,786 |
1,736,194,000 |
| ≡ |
AKO Capital |
3.41 |
Reduce 19.22% |
423,473 |
261,948,000 |
| ≡ |
William Von Mueffling - Cantillon Capital Management |
3.02 |
Reduce 2.90% |
799,000 |
494,237,000 |
| ≡ |
David Katz - Matrix Asset Advisors |
1.36 |
Reduce 2.16% |
19,753 |
12,219,000 |
| ≡ |
Thomas Gayner - Markel Group |
0.20 |
Add 20.41% |
35,400 |
21,897,000 |
| ≡ |
Torray Funds |
0.03 |
Buy |
403 |
249,000 |
Open Market Insider Buys
| Date Filed |
Reporting Name |
Relationship |
Trans. Date |
Shares |
Price $ |
Total Value $ |
| 06 Oct 2023 |
BOXER MICHAEL A |
SVP and General Counsel |
26 Jun 2023 |
4 |
526.15 |
2,105 |
* "Hold Price" is the last known price at which an investor still held a security. It is the closing price of the security as of the portfolio date (quarter end). This value is only provided when a security is owned by at least two investors. In the case of reporting dates being different, a weighted average price is calculated.
P = Preferred Stock